Pyxis Oncology(PYXS) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 May 14, 2024 PYX-201 Phase 1 trial clinical readout on track for fall of 2024 Dr. Sullivan added, "We plan to dose an additional 16 patients with a focus on five tumor types of interest based on an assessment of factors including immunohistochemistry target expression, stromal volume, unmet medical need, and clinical judgment. Patient recruitment at these dose levels focuses on head and neck squamous c ...